Home > > > Report Detail

Global Pancreatic Beta-Cell Protection Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 05-Oct-2022
No. of pages: 121
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pancreatic Beta-Cell Protection companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Pancreatic Beta-Cell Protection market. Further, it explains the major drivers and regional dynamics of the global Pancreatic Beta-Cell Protection market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- ViaCyte

- PharmaCyte Biotech

- Boehringer Ingelheim

- GalaxoSmithKline

- Beta-Cell NV

- Novartis

- Janssen Research & Development

- Pfizer Inc

- BioLineRx

- Genentech

- Novo Nordisk

- Sanofi

- Osiris Therapeutics

- Beta-O2 Technologies Ltd

- Transition Therapeutics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Pancreatic Beta-Cell Protection Segment by Type

- Stem Cell Based

- Gene Therapies

- RNA Based Therapies

- Monoclonal Antibodies (MAbs)

- Phytotherapy

Pancreatic Beta-Cell Protection Segment by Application

- Hospital

- Medical Research Laboratory

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pancreatic Beta-Cell Protection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Pancreatic Beta-Cell Protection market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Pancreatic Beta-Cell Protection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pancreatic Beta-Cell Protection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pancreatic Beta-Cell Protection revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Pancreatic Beta-Cell Protection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Pancreatic Beta-Cell Protection revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, GalaxoSmithKline, Beta-Cell NV, Novartis, Janssen Research & Development, Pfizer Inc and BioLineRx, etc.

Global Pancreatic Beta-Cell Protection Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pancreatic Beta-Cell Protection Market Size (2017-2028)
2.2 Pancreatic Beta-Cell Protection Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Pancreatic Beta-Cell Protection Market Size by Region (2017-2022)
2.4 Global Pancreatic Beta-Cell Protection Market Size Forecast by Region (2023-2028)
2.5 Global Top Pancreatic Beta-Cell Protection Countries Ranking by Market Size
3 Pancreatic Beta-Cell Protection Competitive by Company
3.1 Global Pancreatic Beta-Cell Protection Revenue by Players
3.1.1 Global Pancreatic Beta-Cell Protection Revenue by Players (2017-2022)
3.1.2 Global Pancreatic Beta-Cell Protection Market Share by Players (2017-2022)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2021
3.5 Global Pancreatic Beta-Cell Protection Key Players Head office and Area Served
3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Revenue by Type (2017-2022)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Revenue by Type (2023-2028)
5 Global Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2017-2022)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Revenue by Company (2020-2022)
6.2 North America Pancreatic Beta-Cell Protection Revenue by Type (2017-2028)
6.3 North America Pancreatic Beta-Cell Protection Revenue by Application (2017-2028)
6.4 North America Pancreatic Beta-Cell Protection Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Revenue by Company (2020-2022)
7.2 Europe Pancreatic Beta-Cell Protection Revenue by Type (2017-2028)
7.3 Europe Pancreatic Beta-Cell Protection Revenue by Application (2017-2028)
7.4 Europe Pancreatic Beta-Cell Protection Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Pancreatic Beta-Cell Protection Revenue by Company (2020-2022)
8.2 Asia Pacific Pancreatic Beta-Cell Protection Revenue by Type (2017-2028)
8.3 Asia Pacific Pancreatic Beta-Cell Protection Revenue by Application (2017-2028)
8.4 Asia Pacific Pancreatic Beta-Cell Protection Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Revenue by Company (2020-2022)
9.2 Latin America Pancreatic Beta-Cell Protection Revenue by Type (2017-2028)
9.3 Latin America Pancreatic Beta-Cell Protection Revenue by Application (2017-2028)
9.4 Latin America Pancreatic Beta-Cell Protection Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Company (2020-2022)
10.2 Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Type (2017-2028)
10.3 Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Application (2017-2028)
10.4 Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Products and Services
11.1.4 ViaCyte Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.1.5 ViaCyte Pancreatic Beta-Cell Protection SWOT Analysis
11.1.6 ViaCyte Recent Developments
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Details
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Products and Services
11.2.4 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.2.5 PharmaCyte Biotech Pancreatic Beta-Cell Protection SWOT Analysis
11.2.6 PharmaCyte Biotech Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Products and Services
11.3.4 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.3.5 Boehringer Ingelheim Pancreatic Beta-Cell Protection SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Details
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Products and Services
11.4.4 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.4.5 GalaxoSmithKline Pancreatic Beta-Cell Protection SWOT Analysis
11.4.6 GalaxoSmithKline Recent Developments
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Details
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Products and Services
11.5.4 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.5.5 Beta-Cell NV Pancreatic Beta-Cell Protection SWOT Analysis
11.5.6 Beta-Cell NV Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Products and Services
11.6.4 Novartis Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.6.5 Novartis Pancreatic Beta-Cell Protection SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Details
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Products and Services
11.7.4 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.7.5 Janssen Research & Development Pancreatic Beta-Cell Protection SWOT Analysis
11.7.6 Janssen Research & Development Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Products and Services
11.8.4 Pfizer Inc Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.8.5 Pfizer Inc Pancreatic Beta-Cell Protection SWOT Analysis
11.8.6 Pfizer Inc Recent Developments
11.9 BioLineRx
11.9.1 BioLineRx Company Details
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Products and Services
11.9.4 BioLineRx Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.9.5 BioLineRx Pancreatic Beta-Cell Protection SWOT Analysis
11.9.6 BioLineRx Recent Developments
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Products and Services
11.10.4 Genentech Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.10.5 Genentech Pancreatic Beta-Cell Protection SWOT Analysis
11.10.6 Genentech Recent Developments
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Details
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Products and Services
11.11.4 Novo Nordisk Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.11.5 Novo Nordisk Recent Developments
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Products and Services
11.12.4 Sanofi Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.12.5 Sanofi Recent Developments
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Details
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Products and Services
11.13.4 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.13.5 Osiris Therapeutics Recent Developments
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Details
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Products and Services
11.14.4 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.14.5 Beta-O2 Technologies Ltd Recent Developments
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Details
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Products and Services
11.15.4 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.15.5 Transition Therapeutics Recent Developments
12 Pancreatic Beta-Cell Protection Market Dynamics
12.1 Pancreatic Beta-Cell Protection Market Trends
12.2 Pancreatic Beta-Cell Protection Market Drivers
12.3 Pancreatic Beta-Cell Protection Market Challenges
12.4 Pancreatic Beta-Cell Protection Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Stem Cell Based
Table 3. Key Players of Gene Therapies
Table 4. Key Players of RNA Based Therapies
Table 5. Key Players of Monoclonal Antibodies (MAbs)
Table 6. Key Players of Phytotherapy
Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Pancreatic Beta-Cell Protection Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Pancreatic Beta-Cell Protection Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Pancreatic Beta-Cell Protection Revenue Market Share by Region (2017-2022)
Table 11. Global Pancreatic Beta-Cell Protection Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Pancreatic Beta-Cell Protection Market Share by Players (2017-2022)
Table 13. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
Table 14. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Pancreatic Beta-Cell Protection Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2022)
Table 22. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2023-2028)
Table 24. Global Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2022)
Table 26. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2023-2028)
Table 28. North America Pancreatic Beta-Cell Protection Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Pancreatic Beta-Cell Protection Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Pancreatic Beta-Cell Protection Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Pancreatic Beta-Cell Protection Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Pancreatic Beta-Cell Protection Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Pancreatic Beta-Cell Protection Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Pancreatic Beta-Cell Protection Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Pancreatic Beta-Cell Protection Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Pancreatic Beta-Cell Protection Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Pancreatic Beta-Cell Protection Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Pancreatic Beta-Cell Protection Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Pancreatic Beta-Cell Protection Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Pancreatic Beta-Cell Protection Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Pancreatic Beta-Cell Protection Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pancreatic Beta-Cell Protection Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Pancreatic Beta-Cell Protection Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Pancreatic Beta-Cell Protection Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Pancreatic Beta-Cell Protection Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Pancreatic Beta-Cell Protection Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Pancreatic Beta-Cell Protection Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Pancreatic Beta-Cell Protection Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Pancreatic Beta-Cell Protection Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Country (2023-2028) & (US$ Million)
Table 63. ViaCyte Company Details
Table 64. ViaCyte Business Overview
Table 65. ViaCyte Pancreatic Beta-Cell Protection Product and Services
Table 66. ViaCyte Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 67. ViaCyte Pancreatic Beta-Cell Protection SWOT Analysis
Table 68. ViaCyte Recent Developments
Table 69. PharmaCyte Biotech Company Details
Table 70. PharmaCyte Biotech Business Overview
Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product and Services
Table 72. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 73. PharmaCyte Biotech Pancreatic Beta-Cell Protection SWOT Analysis
Table 74. PharmaCyte Biotech Recent Developments
Table 75. Boehringer Ingelheim Company Details
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product and Services
Table 78. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 79. Boehringer Ingelheim Pancreatic Beta-Cell Protection SWOT Analysis
Table 80. Boehringer Ingelheim Recent Developments
Table 81. GalaxoSmithKline Company Details
Table 82. GalaxoSmithKline Business Overview
Table 83. GalaxoSmithKline Pancreatic Beta-Cell Protection Product and Services
Table 84. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 85. GalaxoSmithKline Pancreatic Beta-Cell Protection SWOT Analysis
Table 86. GalaxoSmithKline Recent Developments
Table 87. Beta-Cell NV Company Details
Table 88. Beta-Cell NV Business Overview
Table 89. Beta-Cell NV Pancreatic Beta-Cell Protection Product and Services
Table 90. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 91. Beta-Cell NV Pancreatic Beta-Cell Protection SWOT Analysis
Table 92. Beta-Cell NV Recent Developments
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Pancreatic Beta-Cell Protection Product and Services
Table 96. Novartis Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 97. Novartis Pancreatic Beta-Cell Protection SWOT Analysis
Table 98. Novartis Recent Developments
Table 99. Janssen Research & Development Company Details
Table 100. Janssen Research & Development Business Overview
Table 101. Janssen Research & Development Pancreatic Beta-Cell Protection Product and Services
Table 102. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 103. Janssen Research & Development Pancreatic Beta-Cell Protection SWOT Analysis
Table 104. Janssen Research & Development Recent Developments
Table 105. Pfizer Inc Company Details
Table 106. Pfizer Inc Business Overview
Table 107. Pfizer Inc Pancreatic Beta-Cell Protection Product and Services
Table 108. Pfizer Inc Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 109. Pfizer Inc Pancreatic Beta-Cell Protection SWOT Analysis
Table 110. Pfizer Inc Recent Developments
Table 111. BioLineRx Company Details
Table 112. BioLineRx Business Overview
Table 113. BioLineRx Pancreatic Beta-Cell Protection Product and Services
Table 114. BioLineRx Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 115. BioLineRx Pancreatic Beta-Cell Protection SWOT Analysis
Table 116. BioLineRx Recent Developments
Table 117. Genentech Company Details
Table 118. Genentech Business Overview
Table 119. Genentech Pancreatic Beta-Cell Protection Product and Services
Table 120. Genentech Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 121. Genentech Pancreatic Beta-Cell Protection SWOT Analysis
Table 122. Genentech Recent Developments
Table 123. Novo Nordisk Company Details
Table 124. Novo Nordisk Business Overview
Table 125. Novo Nordisk Pancreatic Beta-Cell Protection Product and Services
Table 126. Novo Nordisk Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 127. Novo Nordisk Recent Developments
Table 128. Sanofi Company Details
Table 129. Sanofi Business Overview
Table 130. Sanofi Pancreatic Beta-Cell Protection Product and Services
Table 131. Sanofi Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 132. Sanofi Recent Developments
Table 133. Osiris Therapeutics Company Details
Table 134. Osiris Therapeutics Business Overview
Table 135. Osiris Therapeutics Pancreatic Beta-Cell Protection Product and Services
Table 136. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 137. Osiris Therapeutics Recent Developments
Table 138. Beta-O2 Technologies Ltd Company Details
Table 139. Beta-O2 Technologies Ltd Business Overview
Table 140. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product and Services
Table 141. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 142. Beta-O2 Technologies Ltd Recent Developments
Table 143. Transition Therapeutics Company Details
Table 144. Transition Therapeutics Business Overview
Table 145. Transition Therapeutics Pancreatic Beta-Cell Protection Product and Services
Table 146. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 147. Transition Therapeutics Recent Developments
Table 148. Pancreatic Beta-Cell Protection Market Trends
Table 149. Pancreatic Beta-Cell Protection Market Drivers
Table 150. Pancreatic Beta-Cell Protection Market Challenges
Table 151. Pancreatic Beta-Cell Protection Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Beta-Cell Protection Sales Market Share by Type: 2021 VS 2028
Figure 2. Stem Cell Based Features
Figure 3. Gene Therapies Features
Figure 4. RNA Based Therapies Features
Figure 5. Monoclonal Antibodies (MAbs) Features
Figure 6. Phytotherapy Features
Figure 7. Global Pancreatic Beta-Cell Protection Sales Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Medical Research Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Pancreatic Beta-Cell Protection Report Years Considered
Figure 12. Global Pancreatic Beta-Cell Protection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pancreatic Beta-Cell Protection Market Size 2017-2028 (US$ Million)
Figure 14. Global Pancreatic Beta-Cell Protection Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Pancreatic Beta-Cell Protection Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Pancreatic Beta-Cell Protection Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Pancreatic Beta-Cell Protection Market Share by Players in 2021
Figure 18. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2021
Figure 20. North America Pancreatic Beta-Cell Protection Revenue Market Share by Company in 2021
Figure 21. North America Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2028)
Figure 22. North America Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2028)
Figure 23. North America Pancreatic Beta-Cell Protection Revenue Share by Country (2017-2028)
Figure 24. U.S. Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Company in 2021
Figure 27. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2028)
Figure 28. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2028)
Figure 29. Europe Pancreatic Beta-Cell Protection Revenue Share by Country (2017-2028)
Figure 30. Germany Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 31. France Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Pancreatic Beta-Cell Protection Revenue Share by Region (2017-2028)
Figure 39. China Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 42. India Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 44. China Taiwan Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Pancreatic Beta-Cell Protection Revenue Market Share by Company in 2021
Figure 49. Latin America Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Pancreatic Beta-Cell Protection Revenue Share by Country (2017-2028)
Figure 52. Mexico Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Share by Country (2017-2028)
Figure 59. Turkey Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Pancreatic Beta-Cell Protection Revenue (2017-2028) & (US$ Million)
Figure 62. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 63. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 65. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 66. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 67. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 68. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 69. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 70. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 71. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 72. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 73. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 74. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 75. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 76. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs